- Serum Anti-BRAT1 is a Common Molecular Biomarker for Gastrointestinal Cancers and Atherosclerosis
Liubing Hu et al, 2022, Frontiers in Oncology CrossRef - The Nursing Effect of Individualized Management on Patients With Diabetes Mellitus Type 2 and Hypertension
Ran Li et al, 2022, Frontiers in Endocrinology CrossRef - Low anti-CFL1 antibody with high anti-ACTB antibody is a poor prognostic factor in esophageal squamous cell carcinoma
Masaaki Ito et al, 2022, Esophagus CrossRef - Association of Serum Anti-PCSK9 Antibody Levels with Favorable Postoperative Prognosis in Esophageal Cancer
Masaaki Ito et al, 2021, Frontiers in Oncology CrossRef - Utility of atherosclerosis-associated serum antibodies against colony-stimulating factor 2 in predicting the onset of acute ischemic stroke and prognosis of colorectal cancer
Shu-Yang Li et al, 2023, Frontiers in Cardiovascular Medicine CrossRef - Serum anti-AP3D1 antibodies are risk factors for acute ischemic stroke related with atherosclerosis
Shu-Yang Li et al, 2021, Scientific Reports CrossRef - Serum anti‑KIAA0513 antibody as a common biomarker for mortal atherosclerotic and cancerous diseases
Takaki Hiwasa et al, 2024, Medicine International CrossRef - Serum anti-DIDO1, anti-CPSF2, and anti-FOXJ2 antibodies as predictive risk markers for acute ischemic stroke
Takaki Hiwasa et al, 2021, BMC Medicine CrossRef - Serum anti-PCK1 antibody levels are a prognostic factor for patients with diabetes mellitus
Toshiki Namiki et al, 2023, BMC Endocrine Disorders CrossRef - Combination of high anti‐SKI and low anti‐TMED5 antibody levels is preferable prognostic factor in esophageal carcinoma
Masaaki Ito et al, 2024, Cancer Science CrossRef